Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of Glimepiride
NCT00633425
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
43
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus
Interventions
DRUG:
GLIMEPIRIDE
Sponsor
Sanofi